Yasi Baiani is a product, marketing and strategy executive, advisor, and investor with a track record of delivering cutting-edge products that are adopted by millions of people and defining new categories and markets.

Yasi is currently SVP of Product and Marketing at Cleo, where she leads Cleo’s product strategy and innovation as well as marketing. Yasi is also Co-Founder and Chief of Product at Raya Capital, where she advises founders and CEOs and invests in technology and health tech companies. Her investments include Virta Health ($2B valuation), Nova AI (acquired by Highspot which valued at $3.5B), and Lemonaid Health (acquired by 23&Me). Yasi is also an investor through FlyBridge-Harvard Business School (HBS) Alumni Fund, where a group of HBS alumni has come together with Flybridge Capital Partners to invest in seed-stage companies and support the founders to build and scale their businesses.

Prior to joining Cleo, Yasi was the Teladoc’s Head of Mental Health Product, where she built the first integrated Livongo / Teladoc product. Previously, as the Head of Product, Software Experiences at Fitbit, she strategized and built the next generation of health and wellness offerings such as Sleep (the most-engaged part of Fitbit mobile app) as well as Female Health (gained 2.4 million users within the first month of launch) that contributed to selling 60M devices and grew revenue by 195% from $745M to $2.2B.

Yasi was featured as one of The 27 Most Impressive Harvard MBAs by Business Insider and recognized as a LinkedIn Top Voice in technology and digital health for 3 years. Yasi’s expertise in product management led her to be a sought-after Lecturer at the Haas School of Business, UC Berkeley and a public speaker.

Yasi received her MBA from Harvard Business School and her BS in Business Administration from the Haas School of Business, UC Berkeley.